Hypoxic cell radiosensitizers: Expectations and progress in drug development
- 1 February 1985
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 11 (2), 323-329
- https://doi.org/10.1016/0360-3016(85)90154-3
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508International Journal of Radiation Oncology*Biology*Physics, 1984
- The effect of vitamin b6 on the neurotoxicity and pharmacology of desmethylmisonidazole and misonidazole: Clinical and laboratory studiesInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: A preliminary reportInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Clinical trials of radiosensitizers: What should we expect?International Journal of Radiation Oncology*Biology*Physics, 1984
- Clinical perspectives for the use of new hypoxic cell sensitizersInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Initial pharmacology and toxicology of intravenous desmethylmisonidazoleInternational Journal of Radiation Oncology*Biology*Physics, 1982
- SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical useInternational Journal of Radiation Oncology*Biology*Physics, 1981
- A marker for hypoxic cells in tumours with potential clinical applicabilityBritish Journal of Cancer, 1981
- Distribution of misonidazole in human tumours and normal tissuesBritish Journal of Cancer, 1979
- Clinical trials of radiotherapy in hyperbaric oxygen at Portsmouth, 1964–1976Clinical Radiology, 1978